Rare
lephants
Screener
Toggle theme
Inogen, Inc.
INGN
·
Healthcare, Medical Devices, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2024
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
Total Cash from Operations:
$14.8M
Line Item
Value
% of Total
Capital Expenditures
$2.0M
13.6%
Working Capital
$1.6M
10.8%
Net Cash Flow
$11.2M
75.5%
Download CSV
